Trident Lifeline completes acquisition of 50.49% stake in TLL Parenterals

03 Dec 2024 Evaluate

Trident Lifeline has completed acquisition of additional 50.49% of the total issued and paid-up share capital of TLL Parenterals (TPL), by way of new allotment of equity shares and making TPL as a subsidiary of the Company. 

This acquisition would allow the company to partner with the leading and fast-growing market of organic and inorganic chemicals along with pharmaceuticals and allied products.

Trident Lifeline is engaged in the manufacturing and marketing of quality finished dosages.

Trident Lifeline Share Price

280.00 -8.00 (-2.78%)
04-Dec-2024 14:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.35
Dr. Reddys Lab 1218.75
Cipla 1498.65
Lupin 2092.80
Zydus Lifesciences 969.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.